Journal
TRENDS IN BIOTECHNOLOGY
Volume 25, Issue 5, Pages 224-230Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2007.03.003
Keywords
-
Categories
Ask authors/readers for more resources
Embryonic stem cells provide a potential resource for research and drug screening. To make such a resource feasible, it is necessary to generate cells of sufficient quality and quantity. The challenge is to expand cell numbers while maintaining the fidelity of phenotype and to control and direct differentiation to produce the cell type of interest in a format that is suitable for drug screening. At present, large-scale culturing of human ES cell lines is problematic and provides substantial challenges. This article provides an overview of current bioprocessing techniques that could be used to generate cells for drug discovery applications. This will generate further technical expertise that can be applied in the production of cells for potential therapeutic applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available